Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05846620

Pulmonary Immune Cell-microbiome Interactions in the Healthy Lung

Sponsor: Hvidovre University Hospital

View on ClinicalTrials.gov

Summary

The overall aim is to to provide a normal material for the composition and spatial heterogeneity of the following in the healthy lung: i) immune cell populations and their activation patterns, ii) the surrounding cytokine-chemokine milieu, including trans-compartmental fluxes of these mediators between the lung and bloodstream, and iii) the lung microbiome. Main hypotheses: * Absolute and relative immune cell counts in bronchoalveolar lavage fluid (BALF) are similar to those previously reported by other methods6,7. * No trans-compartmental flux of cytokines between the lungs and bloodstream is present, but cytokine concentrations (notably IL-6 and IL-8) vary with the immune-cell-microbiome composition. * Immune cell (mainly T cell) activation, differentiation, and gene expression patterns are expected to differ between blood and BALF in a manner that depends on the regional diversity of the pulmonary microbiome.

Official title: Pulmonary Immune Cell-microbiome Interactions in the Healthy Lung: the ILLUMINA-2 Study

Key Details

Gender

All

Age Range

40 Years - 75 Years

Study Type

OBSERVATIONAL

Enrollment

50

Start Date

2023-04-17

Completion Date

2028-11-30

Last Updated

2025-03-17

Healthy Volunteers

No

Conditions

Interventions

PROCEDURE

Bronchoalveolar lavage

Bronchoalveolar lavage in the middle lobe of the right lung and a mini-bronchoalveolar lavage in the upper and lower lobe of the right lung

Locations (1)

Hvidovre Hospital, University of Copenhagen

Hvidovre, Denmark